Huahai Pharmaceutical (600521.SH): Adenosine Cobalamin Capsules obtained drug registration certificate

Zhitong Finance APP News, Huahai Pharmaceutical (600521.SH) announced that the company recently received the "Drug Registration Certificate" for Cobamamide Capsules approved and issued by the National Medical Products Administration. Cobamamide Capsules are indicated for megaloblastic anemia, nutritional anemia, anemia during pregnancy, polyneuritis, radiculitis, trigeminal neuralgia, sciatica, and nerve paralysis; they can also be used as adjunctive treatment for nutritional disorders and leukopenia caused by radiation and drugs.